Live Breaking News & Updates on Biliary Tract Carcinoma

Stay updated with breaking news from Biliary tract carcinoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

European Commission Approves New Frontline Indications for Pembrolizumab Plus Chemo in Select GI Cancers

The European Commission has approved new indications for pembrolizumab in combination with chemotherapy in select patients with gastric or gastroesophageal adenocarcinoma and select patients with biliary tract cancer. ....

European Union , European Commission , Merck Research Laboratories , Eligibility Criteria , Gastric Cancer , Gastroesophageal Cancer , Biliary Tract Carcinoma , Gi Cancers , Gastrointestinal Cancers , Keynote 859 Trial , Keynote 966 Trial ,

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

GUANGZHOU, China, Oct. 30, 2023 Burning Rock Biotech Limited is pleased to announce that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement in the field. ....

Boehringer Ingelheim , Yusheng Han , Master Service Agreement , Burning Rock Biotech Limited , Company Or Burning Rock , China National Medical Products Administration , Rock Biotech Limited , Biliary Tract Carcinoma , Burning Rock ,

Burning Rock and Boehringer Ingelheim Achieves Master Service Agreement in Oncology Companion Diagnostics

Burning Rock Biotech Limited announced that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement in the field of oncology companion diagnostics. This agreement. ....

Boehringer Ingelheimer , Boehringer Ingelgen , Burning Rock Biotech , Master Service Agreement , China National Medical Products Administration , Boehringer Ingelheim , Burning Rock Biotech Limited , Biliary Tract Carcinoma ,

Burning Rock and Boehringer Ingelheim Achieved a Master

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics. ....

Yusheng Han , Boehringer Ingelheim , China National Medical Products Administration , Company Or Burning Rock , Burning Rock Biotech Limited , Master Service Agreement , Rock Biotech Limited , Biliary Tract Carcinoma , Burning Rock , Nasdaq Bnr , Burning Rock Biotech Limited , Early Detection , Boehringer Ingelheim , Oncology Companion Diagnostics ,